Nicotredole
CAS: 29876-14-0
Ref. 3D-FN42126
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 50g | Discontinued | ||
| 100g | Discontinued |
Product Information
- 29876-14-0
- 3-Pyridinecarboxamide, N-[2-(1H-indol-3-yl)ethyl]-
- N-(2-Indol-3-ylethyl)nicotinamide
- N-Nicotinoyltryptamine
- N-[2-(1H-Indol-3-yl)ethyl]-3-pyridinecarboxamide
- N-[2-(1H-Indol-3-yl)ethyl]nicotinamide
- NSC 138472
- Nicotinamide, N-(2-indol-3-ylethyl)-
- Tryptamide
Nicotredole is an amide and fatty acid with a pyrazole ring. It has been shown to have a depressant effect on the central nervous system, which may be due to its ability to inhibit the release of neurotransmitters in the brain. Nicotredole has been shown to have a number of beneficial effects in cells, including inhibiting glucose uptake by blocking the activity of protein kinase C, preventing lipid accumulation by inhibiting mitochondrial beta-oxidation, and reducing oxidative stress by scavenging free radicals. Nicotredole can also regulate glucose levels in diabetic mice and rats. The synthetic pathway for nicotredole is currently unknown, but it is thought that it can be synthesized from caffeine as well as hydrogen bond formation with hydrochloric acid. Nicotredole has also been found to inhibit SIRT2 enzymes and can be used as an anti-aging drug.
